Mike is pursuing his J.D. at Boston College Law School. During his first year at BC, Mike wrote an article for the Boston College Intellectual Property and Technology Forum, focusing on the patent interference proceeding and dispute over patent rights to the recently discovered genetic engineering technology CRISPR-Cas9. He will be serving as an Editor for the Forum in the upcoming school year. While pursuing a degree in Biology, Mike worked as a research assistant on multiple projects, including a study within the Department of Pharmacology at Yale Medical School focused on understanding the biochemical mechanisms underlying the development and progression of the neurodegenerative disease Spinocerebellar Ataxia-13.
By William L. Birks “The court in exceptional cases may award reasonable attorney fees to the prevailing party.” 35 U.S.C. § 285 While every prevailing party would seek attorney fees if they could, it’s important [Read More…]
By Patrick D. Duplessis As we recently reported, the Arterton Inn of Court held its first substantive event on the 2018-2019 session, and WHIPgroup attorneys played a major role in preparing the event. The event, [Read More…]
By Lauren C. Matturri In December 2018 toy company MGA Entertainment Inc. filed a declaratory judgment against Louis Vuitton. This was to preempt the French fashion house from claiming MGA Entertainment’s Pooey Puitton toy was [Read More…]